What is NDC 43353-451?

43353-451 is the product NDC for Triazolam, Triazolam .25 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 43353. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Triazolam?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Triazolam NDC 43353-451 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)43353-451Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43353-0451Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43353-451-30	43353045130	30 TABLET in 1 BOTTLE (43353-451-30)Marketed from Nov 15, 1982
43353-451-53	43353045153	60 TABLET in 1 BOTTLE (43353-451-53)Marketed from Nov 15, 1982

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triazolam
Generic name (nonproprietary): triazolam
Active ingredients: Triazolam — .25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 43353
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 017892
Marketing start: Nov 15, 1982
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 43353-451_fe714ed3-35c9-4c0c-b64c-d6e1ba0e685fSPL ID fe714ed3-35c9-4c0c-b64c-d6e1ba0e685fSPL set ID 97164a9c-4bc7-4f15-829e-5f9e653c7fa5RxCUI 198318UNII 1HM943223R
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443353045130 followed by a unit qualifier and the quantity

Package 43353-0451-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 16, 2017. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Triazolam is indicated for the short-term treatment of insomnia (generally 7–10 days). Use for more than 2–3 weeks requires complete reevaluation of the patient (see WARNINGS ). Prescriptions for triazolam should be written for short-term use (7–10 days) and it should not be prescribed in quantities exceeding a 1-month supply.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 43353-451

What is NDC 43353-451?: 43353-451 is the product NDC for Triazolam, Triazolam .25 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Triazolam.
What is the active ingredient?: Triazolam.
Who is the labeler?: Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 43353. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Triazolam?: 13 other product NDCs are listed under this name. See all Triazolam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Triazolam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Triazolam	Triazolam .25 mg/1	TabletOral	A-S Medication Solutions	50090-7787	50090-7787-0050090-7787-01
Triazolam	Triazolam .25 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1289	70710-1289-0170710-1289-0570710-1289-08
Triazolam	Triazolam .125 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1521	70710-1521-0170710-1521-0570710-1521-08
Triazolam	Triazolam .25 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1162	70771-1162-0170771-1162-0570771-1162-08
Triazolam	Triazolam .125 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1576	70771-1576-0170771-1576-0570771-1576-08
Triazolam	Triazolam .25 mg/1	TabletOral	A-S Medication Solutions	50090-6471	50090-6471-0050090-6471-01
Triazolam	Triazolam .125 mg/1	TabletOral	Ingenus Pharmaceuticals, LLC	50742-645	50742-0645-01
Triazolam	Triazolam .25 mg/1	TabletOral	Ingenus Pharmaceuticals, LLC	50742-646	50742-0646-0150742-0646-05
Triazolam	Triazolam .25 mg/1	TabletOral	Bryant Ranch Prepack	71335-1876	71335-1876-0071335-1876-0171335-1876-02+7 more
Triazolam	Triazolam .25 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-349	72789-0349-30

All 14 Triazolam NDCs

Other NDCs under NDA 017892

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 017892
Product	Strength	Form · route	Labeler	Product NDC
Triazolam	Triazolam .125 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-3717
Triazolam	Triazolam .25 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-3718